Ted Agres

Articles by Ted Agres

The Scientist Placeholder Image

Big pharma sues USPTO

The Scientist Placeholder Image

New patent rules hurt biotech?

The Scientist Placeholder Image

FASEB: Nationalize conflict rules

The Scientist Placeholder Image

'Open access' opening wider

The Scientist Placeholder Image

US Congress drafts funding boost

The Scientist Placeholder Image

Senate to support stem cells -- again

The Scientist Placeholder Image

NIH grantees under the microscope?

The Scientist Placeholder Image

'Looming crisis' from NIH budget

The Scientist Placeholder Image

New agricultural research institute planned

The Scientist Placeholder Image

Best Places to Work 2007: PostDocs

The Scientist Placeholder Image

Best Places to Work for Postdocs 2007

The Scientist Placeholder Image

Concerns about NIH 'Common Fund'

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies